Predictors of smear-negative pulmonary tuberculosis in HIV-infected patients, Battambang, Cambodia

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 3, 2009, Pages 347-354

  Tamhane, A ^a   Chheng, P ^a   Dobbs, T ^a   Mak, S ^b   Sar, B ^c   Kimerling, Michael E ^d,e  

^a University of Alabama at Birmingham   (United States)

^b Provincial Health Department   (Cambodia)

^c INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

^e Global Health Program   (United States)

Author keywords

HIV infected; Predictors; Pulmonary tuberculosis; Smear negative

Indexed keywords

ADULT; AGE; ARTICLE; CAMBODIA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; COUGHING; DIAGNOSTIC PROCEDURE; FEMALE; FEVER; HEMOPTYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PHYSICIAN; PREDICTION AND FORECASTING; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SENSITIVITY AND SPECIFICITY; SMEAR; THORAX RADIOGRAPHY;

ADULT; CAMBODIA; CD4 LYMPHOCYTE COUNT; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 62349129506     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40: 1500-1507.
2. Chheng P, Tamhane A, Natpratan C, et al. Pulmonary tuberculosis among clients visiting a voluntary confidential counseling and testing center, Cambodia. Int J Tuberc Lung Dis 2008; 12 (Suppl 1): S54-S62.
3. Cain K P, Kanara N, Laserson K E, et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int J Tuberc Lung Dis 2007; 11: 1008-1013.
4. World Health Organization, The Stop TB Strategy. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. WHO/HTM/TB/2006.37. Geneva, Switzerland: WHO, 2006.
5. Anonymous. Smear-negative tuberculosis [Editorial]. Tubercle 1980; 61: 113-115.
6. Kim T C, Blackman R S, Heatwole K M, et al. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Am Rev Respir Dis 1984; 129: 264-268.
7. Nair S S, Gothi G D, Naganathan N, et al. Precision estimates of bacteriologically confirmed pulmonary tuberculosis in the general population. Indian J Tuberc 1976; 23: 152-159.
8. Tsao T C, Chung M L, Yang P Y, et al. Significant difference of clinical manifestations between smear-negative and smear-positive tuberculosis. Chest 2004; 126: 834S.
9. Brindle R J, Nunn P P, Githui W, et al. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 1993; 147: 958-961.
10. Colebunders R L, Ryder R W, Nzilambi N, et al. HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am Rev Respir Dis 1989; 139: 1082-1085.
11. Elliott A M, Namaambo K, Allen B W, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tubercle Lung Dis 1993; 74: 191-194.
12. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980; 20: 1-63.
13. Behr M A, Warren S A, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449.
14. Hargreaves N J, Kadzakumanja O, Whitty C J M, et al. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis 2001; 5: 847-854.
15. Samb B, Henzel D, Daley C L, et al. Methods for diagnosing tuberculosis among in-patients in Eastern Africa whose sputum smears are negative. Int J Tuberc Lung Dis 1997; 1: 25-30.
16. Kimerling M, Schuchter J, Chanthol E, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 2002; 6: 988-994.
17. de Queiroz Mello F C, do valle Bastos L G, Soares S L M, et al. Predicting smear-negative tuberculosis with classification trees and logistic regression: a cross-sectional study. BMC Public Health 2006; 6: 43.
18. Bah B, Massari V, Sow O, et al. Useful clues to the presence of smear-negative pulmonary tuberculosis in a West African city. Int J Tuberc Lung Dis 2002; 6: 592-598.
19. den Boon S, White N W, van Lill S W P, et al. An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int J Tuberc Lung Dis 2006; 10: 876-882.
20. Kanaya A K, Glidden D V, Chambers H F. Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest 2001; 120: 349-355.
21. Wisnivesky J P, Kaplan J, Henschke C, et al. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Int Med 2000; 160: 2471-2476.
22. Toman K. Tuberculosis: case finding and chemotherapy: questions and answers. Geneva, Switzerland: World Health Organization, 1979.
23. World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extra-pulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. WHO/HTM/TB/2007.379. Geneva, Switzerland: WHO, 2007.
24. Khan M S, Dar O, Sismanidis C, et al. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial. Lancet 2007; 369: 1955-1960.
25. Nguyen T N, Wells C D, Binkin N J, et al. The importance of quality control of sputum smear microscopy: the effect of reading errors on treatment decisions and outcomes. Int J Tuberc Lung Dis 1999; 3: 483-487.
26. Siddiqi K, Walley J, Khan M A, et al. Clinical guidelines to diagnose smear-negative pulmonary tuberculosis in Pakistan, a country with low HIV prevalence. Trop Med Int Health 2006; 11: 323-331.
27. Samb B, Sow P S, Kony S, et al. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis 1999; 3: 330-336.
28. Karstaedt A S, Jones N, Khoosal M, et al. The bacteriology of pulmonary tuberculosis in a population with high human immunodeficiency virus seroprevalence. Int J Tuberc Lung Dis 1998; 2: 312-316.
29. Jones B E, Young S M M, Antoniskis D, et al. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148: 1292-1297.
30. Griffith D, Aksamit T, Brown-Elliot B A, et al. An official ATS/IDSA statement: diagnosis, treatment and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
31. Sun Z, Scorpio A, Zhang Y. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms. Microbiology 1997; 143: 3367-3373.
32. Mdluli K, Swanson J, Fischer E, et al. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 1998; 27: 1223-1233.